OVER 45 & WORRIED AB...
Services
Semaglutide belongs to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). It works by mimicking the action of incretin hormones in the body, stimulating insulin release, suppressing glucagon secretion, and slowing down gastric emptying. This mechanism aids in controlling blood sugar levels in individuals with type 2 diabetes. Discover the efficacy of semaglutide 15 units in managing type 2 diabetes, aiding weight loss, and potentially reducing cardiovascular risks.
The recommended dosage for Semaglutide is typically 15 units, and the administration frequency may vary depending on the specific formulation and the individual’s response to treatment. It is essential to follow the prescribing physician’s guidance and adhere to the prescribed dosage regimen for optimal therapeutic effects.
Below are general dosage recommendations for Semaglutide 15 units:
Usual Adult Dose for:
- Diabetes Type 2:
- Initial dose: 0.25 mg subcutaneously once weekly for four weeks.
- Maintenance dose: 0.5 mg subcutaneously once weekly. Some individuals may benefit from an increase to 1 mg once weekly based on response and tolerability.
- Cardiovascular Risk Reduction:
- Dosage aligns with the treatment of type 2 diabetes. The cardiovascular benefits are observed in the context of glycemic control.
- Weight Loss:
- For weight management (Wegovy), the recommended dose is typically higher than that used for diabetes.
- The standard dose for weight loss is 2.4 mg subcutaneously once weekly.